CRP and melanoma: Our analysis reveals three core insights: First, biomarker mechanisms are now well-defined across species, with diagnostic tools like CRP in canine sepsis, prognostic indicators such as cfDNA in oncology, and predictive signatures like BRAF in melanoma enabling more targeted interventions.